Publications by authors named "K S Cowart"

Submerged plants can thrive entirely underwater, playing a crucial role in maintaining water quality, supporting aquatic organisms, and enhancing sediment stability. However, they face multiple challenges, including reduced light availability, fluctuating water conditions, and limited nutrient access. Despite these stresses, submerged plants demonstrate remarkable resilience through physiological and biochemical adaptations.

View Article and Find Full Text PDF

Rationale: Recent studies report that fentanyl analogs with relatively low pK values produce antinociception in rodents without other mu opioid-typical side effects due to the restriction of their activity to injured tissue with relatively low pH values. However, it is unclear if and to what degree these compounds may produce mu opioid-typical side effects (respiratory depression, reinforcing effects) at doses higher than those required to produce antinociception.

Objectives: The present study compared the inflammatory antinociceptive, respiratory-depressant, and reinforcing effects of fentanyl and two analogs of intermediate (FF3) and low (NFEPP) pK values in terms of potency and efficacy in male and female Sprague-Dawley rats.

View Article and Find Full Text PDF

Background And Purpose: Attention to wellness in the pharmacy workplace is occurring. To maintain accreditation, pharmacy residency programs must incorporate wellness and resilience initiatives.

Educational Activity And Setting: Orlando Health created a pharmacy residency wellness program for post-graduate year one (PGY-1) and post-graduate year two (PGY-2) pharmacy residents to address wellness and burnout.

View Article and Find Full Text PDF
Article Synopsis
  • Bexagliflozin is shown to lower hemoglobin A1c levels by about 0.5%, along with similar decreases in blood pressure and weight compared to other SGLT2 inhibitors, though there are currently no published cardiovascular outcome trials.
  • The drug’s side effects are comparable to other SGLT2 inhibitors, including risks of genital infections, urinary tract infections, and increased urination, with a specific warning about lower extremity amputation.
  • While bexagliflozin has no available cost-effectiveness data and lacks extensive trial data, it may offer a competitive price; however, other SGLT2 inhibitors like empagliflozin or dapaglif
View Article and Find Full Text PDF